rIFN-γ-mediated growth suppression of platinum-sensitive and -resistant ovarian tumor cell lines not dependent upon arginase inhibition

per Melichar, Bohuslav, Hu, Wei, Patenia, Rebecca, Melicharová, Karolina, Gallardo, Stacie T, Freedman, Ralph
Publicat 2003

Monocyte/macrophage and T-cell infiltrates in peritoneum of patients with ovarian cancer or benign pelvic disease

per Wang, Xipeng, Deavers, Michael, Patenia, Rebecca, Bassett, Roland L, Mueller, Peter, Ma, Qing, Wang, Ena, Freedman, Ralph S
Publicat 2006

Complement component C3 mediates Th1/Th17 polarization in human T cell activation and cutaneous Graft-versus-Host Disease

per Ma, Qing, Li, Dan, Carreño, Roberto, Patenia, Rebecca, Tsai, Kenneth Y., Xydes-Smith, Marika, Alousi, Amin M., Champlin, Richard E., Sale, George E., Afshar-Kharghan, Vahid
Publicat a Bone Marrow Transplant (2014)

Cytokines, GM-CSF and IFNγ administered by priming and post-chemotherapy cycling in recurrent ovarian cancer patients receiving carboplatin

per Apte, Sachin M, Vadhan-Raj, Saroj, Cohen, Lorenzo, Bassett, Roland L, Gordon, Ilyssa O, Levenback, Charles F, Ramirez, Pedro T, Gallardo, Stacie T, Patenia, Rebecca S, Garcia, Michael E, Iyer, Revathy B, Freedman, Ralph S
Publicat 2006

Reduced GVHD in C3-deficient mice is associated with the decrease of donor Th1/Th17 differentiation

per Ma, Qing, Li, Dan, Nurieva, Roza, Patenia, Rebecca, Bassett, Roland, Cao, Wei, Alekseev, Andrei M., He, Hong, Molldrem, Jeffrey J., Kroll, Michael H., Champlin, Richard E., Sale, George E., Afshar-Kharghan, Vahid
Publicat 2012

Activity of 8F4, a T cell receptor-like anti-PR1/HLA-A2 antibody, against primary human AML in vivo

per Sergeeva, Anna, He, Hong, Ruisaard, Kathryn, St. John, Lisa, Alatrash, Gheath, Clise-Dwyer, Karen, Li, Dan, Patenia, Rebecca, Hong, Richard, Sukhumalchandra, Pariya, You, M. James, Gagea, Mihai, Ma, Qing, Molldrem, Jeffrey J.
Publicat a Leukemia (2016)

Lovastatin inhibits T cell proliferation while preserving the cytolytic function of EBV-, CMV- and MART-1-specific CTLs

per Li, Dan, Li, Yufeng, Hernandez, Jessica A., Patenia, Rebecca, Kim, Tae Kon, Khalili, Jahan, Dougherty, Mark C., Hanley, Patrick J., Bollard, Catherine M., Komanduri, Krishna V., Hwu, Patrick, Champlin, Richard E., Radvanyi, Laszlo G., Molldrem, Jeffrey J., Ma, Qing
Publicat a J Immunother (2010)

Broad Cross-Presentation of the Hematopoietically-Derived PR1 Antigen on Solid Tumors Leads to Susceptibility to PR1-Targeted Immunotherapy

per Alatrash, Gheath, Mittendorf, Elizabeth A., Sergeeva, Anna, Sukhumalchandra, Pariya, Qiao, Na, Zhang, Mao, St John, Lisa S., Ruisaard, Kathryn, Haugen, Christine E., Al-Atrache, Zein, Jakher, Haroon, Philips, Anne V., Ding, Xiaoling, Chen, Jie Qing, Wu, Yun, Patenia, Rebecca S., Bernatchez, Chantale, Vence, Luis M., Radvanyi, Laszlo G., Hwu, Patrick, Clise-Dwyer, Karen, Ma, Qing, Lu, Sijie, Molldrem, Jeffrey J.
Publicat 2012